Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Papaverine on Sublingual Microcirculation in Septic Shock
NCT07657741Not yet recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of papaverine in septic shock, sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoints: Sublingual Microvascular Flow Index at 6 hours and Pcc-Pmsf Gradient at 6 hours. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
papaverine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07657741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657741.